KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abbott Laboratories (ABT) Shares Outstanding (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Shares Outstanding for 17 consecutive years, with $2.0 billion as the latest value for Q4 2025.

  • Quarterly Shares Outstanding changed 0.27% to $2.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 billion through Dec 2025, changed 0.27% year-over-year, with the annual reading at $2.0 billion for FY2025, 0.27% changed from the prior year.
  • Shares Outstanding hit $2.0 billion in Q4 2025 for Abbott Laboratories, roughly flat from $2.0 billion in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $2.0 billion in Q4 2025 to a low of $2.0 billion in Q1 2021.
  • Historically, Shares Outstanding has averaged $2.0 billion across 5 years, with a median of $2.0 billion in 2023.
  • Biggest five-year swings in Shares Outstanding: rose 0.06% in 2022 and later grew 0.32% in 2025.
  • Year by year, Shares Outstanding stood at $2.0 billion in 2021, then rose by 0.06% to $2.0 billion in 2022, then increased by 0.07% to $2.0 billion in 2023, then rose by 0.18% to $2.0 billion in 2024, then grew by 0.27% to $2.0 billion in 2025.
  • Business Quant data shows Shares Outstanding for ABT at $2.0 billion in Q4 2025, $2.0 billion in Q3 2025, and $2.0 billion in Q2 2025.